T2 Biosystems (TTOO) Reports Q4 Revenues Below Estimates; Provides Q1 & FY19 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Canaccord Defends T2 Biosystems (TTOO), Says Refuting the Short Story, Buy on Weakness
March 5, 2019 1:36 PM ESTCanaccord analyst Mark Massaro is defending T2 Biosystems (NASDAQ: TTOO) by saying buy on weakness. Analyst comments: "Shares of T2 Biosystems are down 15% on a short report that appears on Seeking Alpha. As we previewed this morning, T2 is set to... More
White Diamond Research negatived on T2 Biosystems (TTOO), sets $1.50 price target
March 5, 2019 10:03 AM ESTWhite Diamond Research negatived on T2 Biosystems (NASDAQ: TTOO), sets $1.50 price target (LINK)
